“We are deeply concerned by the critical COVID-19 situation in India, and our hearts go out to you, your loved ones and all the people of India,” says Pfizer Chairman and CEO Albert Bourla
Global pharma major Pfizer is sending its medicines worth $70 million (over ₹510 crore), from its distribution centres in the U.S., Europe and Asia, that have been identified as part of India’s COVID-19 treatment protocol, the company’s Chairman and CEO Albert Bourla said on May 3.
“We are deeply concerned by the critical COVID-19 situation in India, and our hearts go out to you, your loved ones and all the people of India,” he said in a mail sent to Pfizer India employees that he has shared on his linked.in post.
“We are committed to being a partner in India’s fight against this disease and are quickly working to mobilise the largest humanitarian relief effort in our company’s history,” Mr. Bourla said.
Right now, Pfizer colleagues at distribution centres in the U.S., Europe and Asia are hard at work rushing shipments of Pfizer medicines that the Government of India has identified as part of its COVID-19 treatment protocol, he added.
“We are donating these medicines to help make sure that every COVID-19 patient in every public hospital across the country can have access to the Pfizer medicines they need free of charge,” Mr. Bourla said.
These medicines, valued at more than $70 million, will be made available immediately, and “we will work closely with the government and our NGO partners to get them to where they are needed most,” he added.